TCBP Historical Income Statement
| TCBP Stock | USD 0.64 0.02 3.03% |
Historical analysis of TC BioPharm income statement accounts such as Total Revenue of 0.0, Gross Profit of 3.1 M, Other Operating Expenses of 6.2 M or Research Development of 5.9 M can show how well TC BioPharm Holdings performed in making a profits. Evaluating TC BioPharm income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of TC BioPharm's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining TC BioPharm Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether TC BioPharm Holdings is a good buy for the upcoming year.
TCBP |
About TCBP Income Statement Analysis
TC BioPharm Holdings Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to TC BioPharm shareholders. The income statement also shows TCBP investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
TC BioPharm Income Statement Chart
Add Fundamental
Gross Profit
Gross profit is a required income statement account that reflects total revenue of TC BioPharm Holdings minus its cost of goods sold. It is profit before TC BioPharm operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of TC BioPharm Holdings. It is also known as TC BioPharm overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from TC BioPharm's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into TC BioPharm Holdings current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TC BioPharm Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. At this time, TC BioPharm's Depreciation And Amortization is relatively stable compared to the past year. As of 11/27/2024, Reconciled Depreciation is likely to grow to about 736.6 K, while Interest Income is likely to drop 1,888.
| 2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 812.0K | 762.5K | 630.1K | 638.0K | Interest Income | 33.0 | 2.2K | 2.0K | 1.9K |
TC BioPharm income statement Correlations
Click cells to compare fundamentals
TC BioPharm Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with TC BioPharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TC BioPharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will appreciate offsetting losses from the drop in the long position's value.Moving together with TCBP Stock
| 0.67 | A | Agilent Technologies Sell-off Trend | PairCorr |
| 0.85 | ME | 23Andme Holding | PairCorr |
| 0.76 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
Moving against TCBP Stock
| 0.67 | MDGL | Madrigal Pharmaceuticals | PairCorr |
| 0.46 | KZR | Kezar Life Sciences | PairCorr |
| 0.41 | MLYS | Mineralys Therapeutics, | PairCorr |
| 0.37 | KEP | Korea Electric Power | PairCorr |
The ability to find closely correlated positions to TC BioPharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TC BioPharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TC BioPharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TC BioPharm Holdings to buy it.
The correlation of TC BioPharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TC BioPharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TC BioPharm Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TC BioPharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for TCBP Stock Analysis
When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.